SK

Susheela Kothari

Director Director DIN 09675239
DIN 09675239 First appointment Jul 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2022
Shareholding value •••• Premium profile

About Susheela Kothari

Data last updated:

Susheela Kothari was a Director at Sapna Pharmaceuticals Private Limited (2023–2025) and Director at Rajsons Pharma Private Limited (2022–2023). The companies operate in Pharma.

DIN 09675239
Primary Designation Director
Industry Pharma
First Appointment 16 Jul 2022

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Mar 20232011₹49.88 Cr (FY 2024)Active
Rajsons Pharma Private Limited U85100KA2011PTC057848
Director16 Jul 20222011₹440 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sapna Pharmaceuticals Private Limited
Rajsons Pharma Private Limited
Premium access

Shareholding and investment profile for Susheela Kothari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Susheela Kothari

Susheela Kothari was first appointed on 16 Jul 2022 as Director at Rajsons Pharma Private Limited. The most recent appointment on record is 20 Mar 2023 at Sapna Pharmaceuticals Private Limited.

Susheela Kothari held 2 earlier board appointments: Sapna Pharmaceuticals Private Limited (Director, 20 Mar 2023 to 14 Feb 2025); Rajsons Pharma Private Limited (Director, 16 Jul 2022 to 23 Mar 2023).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available